Literature DB >> 29264436

Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.

Giovanni Battista Levi Sandri1, Giuseppe Maria Ettorre1, Valerio Giannelli2, Marco Colasanti1, Rosa Sciuto3, Giuseppe Pizzi4, Roberto Cianni5, Gianpiero D'Offizi6, Mario Antonini7, Giovanni Vennarecci1, Pierleone Lucatelli8.   

Abstract

Liver transplantation (LT) for hepatocellular carcinoma (HCC) within the Milan criteria (MC) is nowadays a curative procedure. Yttrium-90 microspheres radioembolization (Y90-RE) has shown to be an effective and safe treatment of primary liver tumors. The aim of this work is to offer a view on the publications which report on the use of Y90-RE as bridge or downstaging prior to LT. Twenty articles have been considered for this world review. About 178 LT in patients were treated with Y90-RE prior to LT. Most of patients had a downstaging strategy. In all series alpha-fetoproteins decreased between Y90-RE and LT. Therefore, Y90-RE may have an important role in the bridge and downstaging treatments.

Entities:  

Keywords:  Yttrium; bridging; downstaging; hepatocellular carcinoma (HCC); liver transplantation (LT); radioembolization

Year:  2017        PMID： 29264436      PMCID： PMC5723750          DOI： 10.21037/tgh.2017.11.11

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


  43 in total

1.  Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.

Authors:  Giuseppe Maria Ettorre; Roberto Santoro; Claudio Puoti; Rosa Sciuto; Livio Carpanese; Mario Antonini; Giorgio Antonucci; Carlo L Maini; Lucia Miglioresi; Giovanni Vennarecci
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

Review 2.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

3.  Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.

Authors:  Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Andrea Laurenzi; Marco Colasanti; Roberto Luca Meniconi; Raffaella Lionetti; Roberto Santoro; Pasquale Lepiane; Rosa Sciuto; Giuseppe Pizzi; Roberto Cianni; Rita Golfieri; Gianpiero D'Offizi; Adriano M Pellicelli; Mario Antonini; Giovanni Vennarecci
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

4.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

5.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Authors:  Francis Y Yao; Ryutaro Hirose; Jeanne M LaBerge; Timothy J Davern; Nathan M Bass; Robert K Kerlan; Raphael Merriman; Sandy Feng; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

Review 6.  Liver metastases from colorectal cancer: radioembolization with systemic therapy.

Authors:  Nils H Nicolay; David P Berry; Ricky A Sharma
Journal:  Nat Rev Clin Oncol       Date:  2009-11-03       Impact factor: 66.675

Review 7.  Liver transplantation after radioembolization in a patient with unresectable HCC.

Authors:  Laura E Moreno Luna; Paul Y Kwo; Lewis R Roberts; Teresa A Mettler; Denise N Gansen; James C Andrews; Gregory A Wiseman; Vijay Laxmi Misra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

8.  Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.

Authors:  Michael Vouche; Laura Kulik; Rohi Atassi; Khairuddin Memon; Ryan Hickey; Daniel Ganger; Frank H Miller; Vahid Yaghmai; Michael Abecassis; Talia Baker; Mary Mulcahy; Ritu Nayar; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2013-10-01       Impact factor: 17.425

9.  Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.

Authors:  Samer Tohme; Daniel Sukato; Hui-Wei Chen; Nikhil Amesur; Albert B Zajko; Abhinav Humar; David A Geller; James W Marsh; Allan Tsung
Journal:  J Vasc Interv Radiol       Date:  2013-11       Impact factor: 3.464

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  6 in total

1.  Liver transplant for patients outside Milan criteria.

Authors:  Giovanni Battista Levi Sandri; Michel Rayar; Xingshun Qi; Pierleone Lucatelli
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-26

2.  Recent innovations in the management of hepatocellular cancer in the setting of liver transplantation: preface.

Authors:  Giovanni Battista Levi Sandri; Quirino Lai
Journal:  Transl Gastroenterol Hepatol       Date:  2018-02-06

3.  Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?

Authors:  Tamás Benkö; Julia König; Jens M Theysohn; Clemens Schotten; Fuat H Saner; Jürgen Treckmann; Sonia Radunz
Journal:  Eur J Med Res       Date:  2022-05-26       Impact factor: 4.981

4.  Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.

Authors:  Mohammad Elsayed; William Wagstaff; Keywan Behbahani; Alexander Villalobos; Zachary Bercu; Bill S Majdalany; Mehmet Akce; David M Schuster; Hui Mao; Nima Kokabi
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-26       Impact factor: 2.740

5.  Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.

Authors:  Jacob J Adashek; Meghan Salgia; Nazli Dizman; Jonathan Kessler; Sumanta K Pal
Journal:  Case Rep Oncol       Date:  2018-05-17

Review 6.  Updates on the Diagnosis and Management of Hepatocellular Carcinoma.

Authors:  Aimun Raees; Muhammad Kamran; Hasan Özkan; Wasim Jafri
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jan-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.